Sexual Health, Anxiety, and Depression in Liver Transplant Candidates and Recipients in Iran
Overview
This study investigates sexual dysfunction, anxiety, and depression among Iranian patients awaiting liver transplantation and those post-transplant. Findings highlight persistent sexual dysfunction and psychological distress in both groups, underscoring the complex interplay between liver disease, transplantation, and mental health.
Background
Liver transplantation is a critical treatment for end-stage liver disease with improving survival rates. Sexual dysfunction is common in chronic liver disease due to hormonal axis disruption and may persist after transplantation. Anxiety and depression are prevalent in patients awaiting and following liver transplant, potentially influencing sexual health. Understanding these relationships is essential for comprehensive patient care.
Data Highlights
The study included 750 participants: 250 pre-transplant patients with MELD scores >20 and 500 post-transplant patients at least three months post-procedure. Validated Persian versions of the Hospital Anxiety and Depression Scale (HADS), International Index of Erectile Function (IIEF), and Female Sexual Function Index (FSFI) were used to assess psychological and sexual health parameters. Random sampling ensured representative selection from the Shiraz liver transplant center, the highest volume center globally.
Key Findings
Sexual dysfunction remains prevalent in approximately 25% of patients after liver transplantation despite theoretical expectations of improvement.
Both pre- and post-transplant patients exhibit significant levels of anxiety and depression, with symptoms persisting up to two years post-transplant.
There is a bidirectional association between sexual dysfunction and psychological distress, where anxiety and depression increase the risk of sexual disorders and vice versa.
Hormonal disruption related to chronic liver disease contributes to sexual dysfunction, which may not fully resolve after transplantation.
Comprehensive assessment using validated tools (HADS, IIEF, FSFI) is feasible and important for identifying patients at risk.
Clinical Implications
Clinicians should routinely screen liver transplant candidates and recipients for sexual dysfunction, anxiety, and depression using validated instruments. Addressing psychological distress may improve sexual health outcomes and overall quality of life. Multidisciplinary care involving mental health support is recommended to optimize post-transplant recovery and patient well-being.
Conclusion
Sexual dysfunction and psychological distress are significant concerns in both liver transplant candidates and recipients. Integrated management strategies targeting these issues are essential to enhance patient outcomes in this population.
References
Montazeri et al. 2003 -- Validation of the Persian version of HADS
